COVID-19 Impact on U.S. PPI Market
Determine if COVID-19 will have an impact on the U.S. proton pump inhibitor market to help complete an understanding of the industry.
Possible Increase in Omeprazole Sales
- Omeprazole (a proton pump inhibitor, or PPI) has been identified as increasing the effectiveness of remdesivir, the first treatment approved for COVID-19 treatment. This will likely increase the demand for products with this ingredient in the U.S.
- Omeprazole increases the activity of remdesivir by 10-fold.
- The amount of increase in sales of omeprazole products will be dependent on how often remdesivir is prescribed. The company that makes remdesivir is preparing for millions of courses to be available soon on the global market.
- If the public is made aware of omeprazole's association with combating COVID-19, sales will increase based on hype. As an example, the antimalarial drug hydroxychloroquine (which has no clinical ability to fight COVID-19) has seen weekly sales increase from 8.5 million to 10.2 million since being declared as a possible treatment by the presidential administration.
- Products in the U.S. based on omeprazole include Prilosec, Prilosec OTC, Omesec, and Zegerid (original formulation).
Increased Obesity Rates Could Fuel Long Term Growth
- The quarantine caused by COVID-19 is causing increased weight gain and obesity, nicknamed the "quarantine 15".
- Rising rates of obesity fuel the demand for PPIs as a result of associated esophageal and gastrointestinal-related diseases.
- Childhood obesity is anticipated to rise as a result of the quarantine, thus increasing the potential customer base for PPIs.
Summary of Early Findings in Relation to Goals
For this hour of research, a high-level search of public information was conducted to determine if the requested information is available.
There is limited public information on the potential impact of COVID-19 on the U.S. PPI market.
There are many market analysis reports that include COVID-19 impact reports on the global PPI market. Some of them (such as the Proton Pump Inhibitors Market Report 2020-2026) offer free samples of the report pending registration; however, access to the free sample was not granted in sufficient time to determine if it has any value.
Based on our findings, we recommend the following next steps:
Proposed next steps:
You need to be the project owner to select a next step.